SightfileU.S. market data from official filings

STEREOTAXIS INC (STXS)

Name: STEREOTAXIS INC (STXS) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001289340 · EDGAR filings · Updated 2026-07-16

STEREOTAXIS INC (STXS) has reported institutional ownership of 43.9%, with 114 institutional managers holding positions valued at $79.0M per the latest 13F reporting period.

Institutional ownership

43.9%

Institutional managers

114

Reported 13F value

$79.0M

Insider activity

14 trans.

$66.6K net buying

Latest updates

2026-07-16 — Current report (8-K) filed
2026-07-15 — Shelf registration (S-3) filed
2026-07-15 — Shelf registration (S-3) filed
2026-07-09 — Current report (8-K) filed
2026-07-01 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, STEREOTAXIS INC has 114 institutional holders and institutional ownership of 43.9%.

Insider activity

Insiders reported 14 transactions (2 buys, 0 sells) across 7 reporting insiders, with a net reported value of $66.6K.

Related companies

GOSSAMER BIO INC (GOSS) · ADLAI NORTYE LTD (ANL) · DIAMEDICA THERAPEUTICS INC (DMAC) · PROMIS NEUROSCIENCES INC (PMN) · APYX MEDICAL CORPORATION (APYX) · PROKIDNEY CORP (PROK)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.